Jyong Biotech Ltd. Gains 51.8%
Tue, Dec 30, 2025 at 07:20 PM
Jyong Biotech Ltd. (MENS:NASDAQ) rocketted at $4.22, a gain of 51.8%. On Tue, Dec 30, 2025, MENS:NASDAQ hit a New 2-Week Intraday Low of $2.75. The stock appeared on our News Catalysts scanner on Fri, Dec 19, 2025 at 11:30 AM in the 'BIOTECH' category. From Wed, Dec 17, 2025, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Mon, Dec 22, 2025 at $7.82 with a volume of 21M+.
About Jyong Biotech Ltd. (MENS:NASDAQ)
Jyong Biotech is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing...
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Ekso Bionics Holdings, Inc. (EKSO:NASDAQ), 93.77%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 92.92%
- Aimei Health Technology Co., Ltd (AFJK:NASDAQ), 89.19%
- Profusa Inc. (PFSA:NASDAQ), 78.33%
- Delixy Holdings Limited (DLXY:NASDAQ), 67.86%
- Santech Holdings Limited (STEC:NASDAQ), 59.38%
- Urgent.ly Inc. (ULY:NASDAQ), 52.49%
- Jyong Biotech Ltd. (MENS:NASDAQ), 51.8%
- Safe and Green Development Corporation (SGD:NASDAQ), 42.26%